EP MedSystems to Present at Security Research Associates Investor
Conference
WEST BERLIN, N.J., Feb. 24 /PRNewswire-FirstCall/ -- EP MedSystems, Inc. (NASDAQ:EPMD), a market leader in electrophysiology products used in cardiac
rhythm management, has been invited to present at Security Research Associates'
Technology and Life Sciences Investor Conference taking place February 28th at
the Campton Place Hotel in San Francisco, California.
EP MedSystems' CFO, Matthew Hill, will discuss the company's market positioning
and growth strategies to expand its leadership in the electrophysiology market. Mr. Hill's general session presentation will take place on Monday, February
28th at approximately 8:40 a.m. PST in the Campton Room III. Mr. Hill will
also conduct detailed one-on-one meetings with investors and analysts
throughout the day. Interested parties should contact the MKR Group Investor
Relations at 818-556-3700 to schedule a meeting.
More information about Security Research Associates' Technology and Life
Sciences Investor Conference can be found at http://www.sresassoc.com/ About EP MedSystems: EP MedSystems develops and markets cardiac electrophysiology ("EP") products
used to diagnose and treat certain cardiac rhythm disorders. The Company's EP
product line includes the EP-WorkMate(R) Electrophysiology Workstation with
RPM(TM)Real-time Position Management(TM) navigation technology, the EP-4(TM)
Computerized Cardiac Stimulator, fixed and deflectable diagnostic
electrophysiology catheters and related disposable supplies, the ALERT(R)
System and ALERT family of internal cardioversion catheters, and the
ViewMate(R) intracardiac ultrasound catheter imaging system. For more
information, visit our Website at http://www.epmedsystems.com/.
Forward Looking Statements: This Release may contain certain statements of a forward-looking nature
relating to future events or the future financial performance of the Company. Forward-looking statements include information concerning our possible or
assumed future results of operations and statements preceded by, followed by or
including the words "believes", "expects", "anticipates", "intends", "plans",
"estimates", or similar expressions. Such forward-looking statements are based
on our management's beliefs and assumptions and on information currently
available to our management. Such forward-looking statements are only
predictions and are subject to risks and uncertainties that could cause actual
results or events to differ materially and adversely from the events discussed
in the forward-looking statements. Factors that could cause or contribute to
such differences include, but are not limited to, EP MedSystems' history of
losses, uncertainty of market acceptance of our products and level of sales,
uncertainty of future profitability and future liquidity needs; and risks
regarding regulatory approvals and demand for new and existing products, as
stated in the Company's Annual Report filed on Form 10-KSB and quarterly
reports filed on Form 10-QSB.
EP MedSystems cautions investors and others to review the cautionary statements
set forth in this press release and in EP MedSystems' reports filed with the
Securities and Exchange Commission and cautions that other factors may prove to
be important in affecting the EP MedSystems' business and results of
operations. Readers are cautioned not to place undue reliance on this press
release and other forward-looking statements, which speak only as of the date
of this press release. EP MedSystems undertakes no obligation to publicly
release the results of any revisions to these forward-looking statements that
may be made to reflect events or circumstances after the date of this press
release or to reflect the occurrence of unanticipated events. DATASOURCE: EP MedSystems CONTACT: Matthew C. Hill, Chief Fin. Officer of EP MedSystems, +1-856-753-8533; or Charles Messman, or Todd Kehrli, both of MKR Group, LLC, +1-818-556-3700, for EP MedSystems Web site: http://www.sresassoc.com/ Web site: http://www.epmedsystems.com/
|